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Abstract 
 
Background: Research on the effects of treating sub-threshold depression in persons with 
diabetes is scarce in spite of the findings indicating that this condition is highly prevalent in 
the diabetic population and may increase the risk of developing a subsequent major 
depression. This study was aimed at exploring the effects of a psycho-educational 
intervention on depression- and diabetes-related outcomes in patients with mild to moderate 
depressive symptoms.  
 
Methods: A randomized controlled study design with a one-year follow-up was used. Fifty 
patients with mild to moderate depressive symptoms (74% female, aged 57±9 yrs, diabetes 
duration of 10±8 yrs, BMI 31±6 kg/m2, HbA1C 7.7%±1.4, 53% insulin treated) were 
randomly assigned to either an intervention or a control group. The intervention group 
underwent four psycho-educational sessions aimed at enabling self-management of depressive 
symptoms. The control group was informed about the screening results and depression 
treatment options while continuing diabetes treatment as usual. Both groups were contacted 
by phone in 2-3-month intervals, and re-assessed for depression after 6 and 12 months. 
Changes in depressive symptoms and glycaemic control were considered primary outcomes. 
Mann-Whitney U test and Friedman ANOVA were used to compare between- and within-
group indicators at 6- and 12-month follow-ups.  
 
Results:  Both the intervention and the control group reported a significant decrease in 
depressive symptoms as measured by the CES-D scale (Friedman ANOVA χ2 =10.8   p=.004 
and χ2 =7.3   p=0.03, respectively). The 6-month and 1-year indicators of glycaemic control as 
compared to baseline HbA1C values were also improved in both groups (χ2 =11.6   p=0.003 
and χ2 =17.1   p=0.0002, respectively). Between-group differences in depressive symptoms 
and HbA1C values were not statistically significant either at 6- or at 12-month follow-up (all 
p > 0.05).  
 
Conclusion: Psycho-educational treatment appears to be beneficial in diabetic patients with 
mild to moderate depressive symptoms, but its effects are comparable with the non-specific 
support given to the subjects in the control group. 
 
Trial registration:  Current Controlled Trials ISRCTN58745372 
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Background  
The prevalence of depression in diabetes is approximately twice as high as in the general 
population [1], implying a synergistic interaction between the two conditions that increases 
the risk of poor health outcomes [2]. 
 
In comparison with patients with diabetes alone, patients with both diabetes and depression 
have been shown to have poorer self-management (i.e. adherence to diet, exercise regimen 
and blood glucose monitoring) and significantly more lapses in refilling oral hypoglycaemic, 
lipid-lowering and antihypertensive prescriptions [3, 4]. Depressed patients with diabetes are 
also significantly more likely to have cardiac risk factors such as smoking, obesity and 
sedentary lifestyle, compared to those with diabetes alone [5]. Depression is associated with 
an increased risk of metabolic dysregulation [6], micro- and macrovascular complications [7], 
and mortality [8]. 
 
Not only clinical depression but also its sub-threshold forms have been shown to have a 
profound influence on the affected patients’ quality of life [9]. Defined as the presence of 
depressive symptoms that fall short of full diagnostic criteria for major depression or 
dysthymia, sub-threshold depression may be considered to be a part of a continuum of 
depressive disorders [10]. Judd et al. [11] conceptualized unipolar depression as presenting in 
different degrees of severity along a spectrum, with sub-threshold depression being the 
mildest form along the spectrum. It may represent a discrete category of its own but may  also 
represent a prodromal,residual or interepisode symptomatic state in the course of major 
depression [12]. Data from the general population indicate that spontaneous improvement for 
this type of depression is low [13].  A systematic review of the literature on the prognosis of 
minor depression [14] showed that 16-62.3% individuals with sub-threshold depressive 
symptoms still have a minor depression after 5 months to 1 year of follow-up, suggesting that 
for many people this form of depression is chronic or recurrent.  Sub-threshold depression has 
been found to increase the risk of subsequent major depression [15] and suicide [16]. Recent 
studies have uncovered some predictors of conversion from minor depression into its more 
severe clinical forms, chronic illness and medical burden being shown to be among them [17, 
18].  
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As research on treatments for sub-threshold depression in diabetic patients is scarce, data on 
their hypothetical effects on depression- and diabetes-related outcomes are inconclusive. 
There has been only one small randomized placebo-controlled pilot study of pharmacological 
treatment conducted in 15 mildly depressed women with type 2 diabetes [19], its results 
indicating beneficial treatment effects on insulin sensitivity. A small non-randomized study of 
the effects of a psycho-educational intervention on mood and glycaemic control in adults with 
diabetes and visual impairment [20] has shown positive effects on diabetes-related distress as 
measured by the Problem Areas in Diabetes scale, and on glycaemic control. The study has 
demonstrated significant positive correlation between glycaemic control and improvement in 
depression. Both of these studies have employed small sample sizes and study designs that do 
not allow reliable conclusions about the clinical benefits of treating sub-threshold depression 
in persons with diabetes.   
 
The hypothesis of this study was that screening depressive symptoms in diabetic patients 
attending their regular medical check-ups, and including those with sub-threshold depression 
in a psychoeducational intervention accompanied by a structured follow-up, might have 
positive effects on depression- and diabetes-related outcomes as defined as improvement of 
depressive symptoms and glycaemic control. The study was expected to remedy 
methodological inadequacies inherent to previous studies in the field using a randomized 
controlled study design with a one-year follow-up. It was aimed at comparing the effects of 
the psycho-educational intervention in diabetic patients with mild to moderate depressive 
symptoms with those of standard diabetes care including screening for depression and a 
structured follow-up. 
 
In this paper we present baseline and one-year follow-up data of 50 patients randomly 
assigned to the two groups. 
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Methods 
Diabetic patients attending their regular check-ups at the Vuk Vrhovac University Clinic for 
Diabetes, Endocrinology and Metabolic Diseases, a referral centre for the registration, 
treatment and follow-up of patients with diabetes in Croatia, were screened for depression by 
using the Patient Health Questionnaire (PHQ-9). Patients with scores of 10-14 points, which 
indicated mild to moderate depression [21], were the trial’s target group. A history of poor 
literacy, mobility difficulties, visual impairment, drinking problems, co-morbid organic 
psychiatric disorder or psychosis were considered as the exclusion criteria.  
The eligible patients were explained the purpose of the study and requested to give written 
consent to participate. Patients who were willing to be included were randomized to either the 
intervention or the control group by means of sequentially numbered sealed envelopes. 
Patients who refused to participate in the research received their usual diabetes care and were 
excluded from this study. 
Participants in the intervention arm were included in a psycho-educational programme 
consisting of four interactive group sessions. The control subjects continued to receive 
standard diabetes care while being informed about the outcomes of the performed screening 
procedure, and about available treatment modalities. Both groups were followed for one year 
including re-assessments of depressive symptoms and glycaemic control at 6 and 12 months, 
and telephone calls in 2- to 3-month intervals to check on patients’ actions in managing 
depression.    
 
At baseline, the study participants were interviewed using a semi-structured interview 
inquiring about their psychological history (past psychological morbidity, method of 
treatment, course of symptoms, psychological morbidity in family members) and present 
psychosocial situation (family status, professional status, economic circumstances, recent 
stressful experiences, perceived social support).  
Psychological questionnaires Center for Epidemiologic Studies Depression Scale [22], 
Problem Areas in Diabetes [23] scale, health-related quality of life questionnaire [24] and 
Summary of Diabetes Self-Care Activities [25] were applied to collect data about patients' 
emotional state and their experience in living with diabetes. The questionnaires were 
previously psychometrically evaluated in Croatian diabetic patients. 
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The Centre for Epidemiological Studies Depression (CES-D) scale is a 20-item, self-report 
scale that asks respondents to indicate the frequency of experiencing each of the 20 symptoms 
over the previous week. The instrument uses a 4-point response scale ranging from «rarely or 
none of the time» to «most or all of the time» with total scores ranging from 0 to 60. Higher 
scores indicate more severe depressive symptoms. A cut-point of 16 was considered 
indicative of elevated depressive symptoms.  
 
The Problem Areas in Diabetes (PAID) questionnaire is a 20-item, self-report scale that asks 
respondents to rate how much of a problem they find each of the 20 diabetes-related issues. 
The answers are given on a 5-point scale ranging from 0 («not a problem») to 4 («serious 
problem»). The PAID scores are summed (with total scores ranging from 0 to 80) and 
transformed to a 0-100 scale with higher scores indicating more diabetes-related distress. 
Scores > 40 were considered indicative of high distress. 
 
The short-form health survey (SF-12 v2) comprises self-assessments of general health, 
physical functioning, physical roles, bodily pain, vitality, social functioning, emotional roles 
and mental health. The raw scores for particular subscales are transformed to a 0-100 scale 
with higher scores indicating better health-related quality of life. 
 
The Summary of Diabetes Self-Care Activities (SDSCA) is a brief self-report questionnaire of 
diabetes self-management that includes items assessing general diet, specific diet, exercise, 
blood glucose testing, foot care and smoking. The questionnaire asks the respondents about 
the frequency with which they performed self-care activities over the previous 7 days. Higher 
subscale scores indicate more regular performing of the self-care activities included. 
 
Medical data were collected from the patients’ medical records. HbA1c was determined by an 
automated immunoturbidimetric method using Bayer reagents (Tarrytown, Il, USA) on 
Olympus AU600 analyser (Olympus Optical Co., Tokyo, Japan) with a normal range from 3.5 
to 5.7% [26].   
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The intervention arm 
Psycho-education on depression 
 
The psycho-educational intervention comprised 4 interactive small group meetings, each 
lasting for 90 minutes, on the following topics:  
 Symptoms of depression; interaction of depression and diabetes;  
 Alleviating burden of depression through activities and problem solving;  
 Associations between depression and cognitive processes - thoughts, beliefs and attitudes 
that induce and maintain depression; and  
 Developing a personal plan for managing depression-related problems in the future.  
The first two meetings were held within a week of each other, and the third and the fourth at 
two-week intervals. Patients were provided with a self-help manual for overcoming 
depressive difficulties based on the "Coping with depression" course by P.M. Lewinsohn [27, 
28].  The manual was given to the participating patients prior to the first session in order to 
make them familiar with the course contents and to facilitate reflecting their own experiences. 
The manual’s structure aimed to stimulate introducing personal examples and making notes. 
The group sessions consisted of discussing particular topics rather than listening about them.     
A part of the manual was a workbook containing exercises to recognize depressive symptoms, 
become aware of daily activity patterns, plan more pleasurable activities, solve problems by 
using a four-step approach, and to recognize and modify cognitive patterns that contribute to 
maintenance of depression. The exercises were planned as a homework. It included keeping 
mood- and daily activities diary, planning daily activities to include more enjoyable ones, 
practicing a problem solving technique to manage personal problems the patients were faced 
with, and using the acquired knowledge to improve self-awareness, primarily with respect to 
automatic negative thoughts that worsen the depressive mood. The patients’ experiences in 
going through the homework were discussed at the beginning of the subsequent session.  
The manual was tested for comprehensibility and clarity in a group of diabetic patients (N=8) 
with different demographic and disease-related characteristics. For the purpose of this study, 
the programme was partially modified and adjusted to diabetes-specific emotional problems. 
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The control arm 
Depression screening followed by standard diabetes treatment 
The patients screened for depression demonstrating elevated result were given explanation of 
their result and were informed about available treatment options. The control participants 
were contacted by phone at the same intervals as the patients from the intervention group, and 
re-assessed for psychological variables after 6 and 12 months. 
 
Sample size calculation was based on the absolute change in depressive symptoms as 
measured by the CES-D questionnaire from the run-in period to the 6- and 12-month follow-
up assessments. To demonstrate a clinically meaningful difference in the CES-D scores with 
alpha=0.05 and power of 90%, and assuming a common standard deviation of the CES-D 
scores of 8.4, 94 patients would be needed in each group. 
 
These preliminary results were analysed using non-parametric statistics including medians 
and modes to describe measures of central tendencies and variability, Mann-Whitney U test to 
determine between-group differences at the three measurement points, and the Friedman 
ANOVA test to determine within-group differences in depression-related and metabolic 
outcomes. 
 
Results  
Demographic, disease-related and psychological characteristics of the intervention and the 
control group are presented in Table 1. The two groups were comparable with respect to age, 
gender, diabetes duration, body mass index, glycaemic control, depressive symptoms and 
diabetes-related emotional problems (all p > 0.05). Health-related quality of life was 
comparable in both groups with the exception of physical functioning which was shown to be 
slightly better in the intervention group (p=0.02). Self-reported diabetes self-care was similar 
in both groups with respect to healthy eating, exercise, blood glucose self-monitoring and foot 
care (all p>0.05). Adherence to diabetes-specific diet seemed to be greater in the control 
group (p=0.03). The intervention group had a higher level of education than the control group 
(p=0.01).  
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Table 1: Demographic, disease-related and psychological characteristics of the patients 
from the intervention and the control groups 
 
 Intervention group 
Median (25-75) 
Control group 
Median (25-75) 
Z 
 
p 
Age (yrs) 55 (51-62) 58 (53-64) -1.1 0.27 
Female (%) 64 84  0.11 
Education (yrs) 12 (8-14) 11 (8-11) 2.52 0.01** 
Diabetes duration (yrs) 10 (3-14.5) 10.5 (4.5-13.5) -0.51 0.61 
Body mass index (kg/m
2
) 30.8 (26.7-35.8) 30.9 (27.9-30.4) 0.25 0.80 
HbA1C (%) 7.5 (6.4-8.3) 7.7 (6.6-8.9) -0.42 0.68 
PHQ-9 (score) 13 (11-18) 13 (11-15) 0.23 0.81 
CES-D (score) 26 (22-30) 24 (18-35) 1.03 0.31 
PAID (total score) 51 (33-60) 45 (25-58) 0.91 0.36 
           Negative emotions 56 (33-67) 48 (21-63) 0.86 0.40 
           Treatment  33 (17-50) 33 (17-50) -0,23 0.82 
            Food 42 (33-75) 58 (33-75) -0.03 0.98 
            Social support 38 (13-63) 13 (0-50) 1.49 0.14 
SDSCA -diet 4 (3-6) 4 (3-6) 0.07 0.94 
              -specific diet 3.5 (2-5.5) 5.5 (3.5-7) -2.11 0.03* 
              -exercise 3.25 (1.5-5) 3 (1-3.5) 0.75 0.43 
              -blood glucose  
                monitoring 
7 (0.75-5.25) 6.5 (0.5-7) 0.69 0.49 
              -foot care 3.5 (0 –7) 2.5 (0-7) 0.51 0.61 
SF – General health 25 (0-25) 25 (0-50) -0.06 0.95 
         Physical functioning 37.5 (25-50) 17 (0-37.5) 2.36 0.02* 
         Role physical 50 (25-62.75) 50 (31.25-62.5) 0.08 0.94 
         Role emotional 50 (50-50) 50 (32-62.5) -0.30 0.77 
         Bodily pain 50 (25-62.5) 25 (25-75) -0.05 0.96 
         Mental health 38 (25-50) 38 (25-50) -0.45 0.65 
         Vitality 25 (25-50) 50 (25-50) -1.22 0.22 
          Social functioning 37.5 (25-50) 50 (25-75) -1.78 0.07 
 
 
** significant at 99% confidence level 
*   significant at 95% confidence level 
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Between-group differences at the 6- and 12-month follow-up visits are presented in Table 2. 
 
 
Table 2: Comparisons of depressive symptoms and glycaemic control between the 
intervention and the control group at 6 and 12 months  
 
 Absolute change: 
Intervention  
versus  
Control group 
U z p 
Depressive symptoms at 6 months 
(CES-D scores) 
 26 (22-30) to 18 (2.5-28.5) 
versus 
 24 (18-35) to 20 (16.5-27) 
264.5 -0.49 0.63 
Depressive symptoms at 12 months 
(CES-D scores) 
26 (22-30) to 19(11-26) 
versus 
24 (18-35) to 19 (15-26) 
 
 
295.5 
 
-0.33 
 
0.74 
Glycaemic control at 6 months 
(HbA1C) 
7.5 (6.4-8.3) to 7.3 (6.3-7.6) 
versus 
7.7 (6.6-8.9) to 6.9 (6.2-8.2) 
 
279.0 
 
0.19 
 
0.86 
Glycaemic control at 12 months 
(HbA1C) 
7.5 (6.4-8.3) to 7.0 (6.0-7.6) 
versus 
7.7 (6.6-8.9) to 7.0 (5.9-7.9) 
 
293.5 
 
-0.13 
 
0.89 
 
Both the intervention and the control group reported less depressive symptoms at the follow-
up assessments and had better glycaemic control as compared to baseline indicators. The 
between-group differences were not statistically significant either at 6- or at 12-month follow-
ups.  
 
Changes in depressive symptoms and HbA1C values for the intervention group are presented 
in Figures 1 and 2. Friedman ANOVA indicated that individuals treated with psycho-
educational intervention reported improved depressive symptoms at the 6-month assessment 
and remained so after 12 months (p=0.004). The same trend could be observed for  HbA1C 
values which were significantly lower at the follow-up assessments, showing an average 
decrease of  0.5% (p=0.0003). 
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Figure 1. 
 
 
Depressive symptoms at baseline and after 6- and 12-month follow-up (Intervention 
arm). Χ2 = 10.8, p = 0.004, Coefficient of concordance = 0.27, Average rank correlation = 
0.23. 
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Figure 2. 
 
 
 
Depressive symptoms at baseline and after 6- and 12-month follow-up (Control arm).  
Χ2 = 7.3, p = 0.03, Coefficient of concordance = 0.19, Average rank correlation = 0.15. 
 
 
Changes in depression-related outcomes and glycaemic control for the control group are 
presented in Figures 3 and 4. Like the intervention group, the control subjects improved their 
depressive symptoms and HbA1C at 6- and 12-month follow-up assessments (p=0.03 and 
p=0.0002 respectively).        
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Figure 3. 
 
 
Glycaemic control at baseline and after 6- and 12-month follow-up (Intervention arm). 
Χ2 = 11.6, p = 0.003, Coefficient of concordance = 0.34, Average rank correlation = 0.30. 
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Figure 4. 
 
 
Glycaemic control at baseline and after 6- and 12-month follow-up (Control arm).  
Χ2 = 17.1, p = 0.002, Coefficient of concordance = 0.45, Average rank correlation = 0.42. 
 
 
 
 
 
Discussion 
The preliminary data on the effects of the psycho-educational intervention in patients with 
mild to moderate depressive symptoms do not support its effectiveness in comparison with 
the non-specific support given to the control patients. A comparable improvement in 
depressive symptoms observed in the patients who were included in the psycho-educational 
group sessions, and in those who were only screened for depression and then followed for one 
year might suggest that treating sub-threshold forms of depression does not demonstrate a 
clear clinical utility. Such a conclusion might be additionally supported by the finding that 
both the intervention and the control participants demonstrated a similar improvement in 
glycaemic control at 6- and 12-month follow-up assessments. These findings suggest that the 
patients included in the study benefited in terms of improved mood and glycaemic control 
regardless of the study arm.      
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There are two hypothetical explanations of the results obtained. The first one concerns the 
structure of the control arm. Although defined as “diabetes treatment as usual” it actually 
implied a more supportive approach than diabetic patients usually receive within their 
standard care. Screening for depression and discussing the results with the patients may be 
considered a kind of an intervention as well. As shown by Pouwer et al. [29], monitoring and 
discussing psychological well-being as part of routine diabetes outpatient care had favourable 
effects on the patients’ mood. Besides monitoring, the control participants in our trial received 
several telephone calls during the follow-up period, and were invited for depression 
reassessment after 6 and 12 months. This could have been experienced as an additional 
support possibly affecting the obtained results. Qualitative data on patients’ experiences with 
participating in the trial collected at the end of the follow-up period support the hypothesis on 
the beneficial effect of monitoring patients’ mood within standard diabetes care.  
 
The second explanation of the obtained results concerns the intervention format and content. 
A short intervention used in the trial relied on cognitive-behavioural principles. It aimed to 
stimulate patients’ activation and improve their capabilities to actively participate in solving 
their internal and external problems. However, some individuals found participation in group 
sessions and exercises difficult. Possibly due to their demographic characteristics (middle age, 
relatively low level of education, limited objective resources) they perceived engagement in 
psychological processes they had not previously practiced as difficult. Their ambivalence 
towards experimenting with new cognitive patterns might be even increased by the fact that, 
although agreeing to the intervention, they actually would not choose it if it were not 
recommended. Being asked about subjectively perceived benefits of the intervention at the 
end of the follow-up, some patients pointed out the new skills they learned, but the majority 
found the experienced support to be most helpful. 
Qualitative data collected from the intervention and the control subjects allow a hypothesis 
that the two study arms had at least one common component, described by the patients as a 
sense of being supported and cared for, and that this component itself seems to be helpful in 
addressing sub-threshold depression in patients with diabetes.  
 
Another relevant finding obtained in the study was that the intervention and the control 
groups comparably improved HbA1C values after 6- and 12-month follow-up periods 
indicating an inverse relation between depressive symptoms and glycaemic control. At 
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present, the relationship between depressive symptoms and glycaemic control is still not fully 
understood. Some studies have proved an undesirable association between depressive 
symptoms and metabolic indicators [6) but others did not confirm such an association [30, 
31]. Effects of treating depressed diabetic individuals on their glycaemic control are also a 
matter of debate, with controversial reports on the association between metabolic 
improvement and reduction in depressive symptoms [32-33].  
Our preliminary data suggest that focusing on patients’ emotional state either in the form of a 
psycho-educational intervention or in the form of monitoring and following-up its further 
development, has positive effects on glycaemic control. 
 
A limitation of this preliminary report is its smaller sample size than indicated by the power 
analysis. However, the preliminary data trend and the qualitative indicators of the patients’ 
benefits gained from participating in the trial make these findings worth reporting. 
Although slightly different with respect to education, self-reported adherence to diabetes-
specific diet and self-reported physical functioning, the two groups could be considered 
basically comparable regarding disease-related and psychological variables. In accordance 
with the literature [34], depressive symptoms in our study participants frequently co-occurred 
with diabetes-related distress suggesting that focus should be equally on monitoring 
depressive symptoms and monitoring emotional distress caused by diabetes.  
Further research relying on bigger sample sizes is needed to determine whether a psycho-
educational intervention may be more efficient than monitoring and following well-being in 
patients with sub-threshold depression. Inquiring into patients’ beliefs about the necessity of 
treating sub-threshold depressive symptoms, and  value-weighted preferences regarding the 
treatment form may be helpful in determining which patients benefit the most. 
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Conclusions  
Preliminary data of the randomised controlled trial aimed at comparing the effects of a 
psycho-educational intervention in patients with mild to moderate depressive symptoms with 
screening for depression accompanied by a structured follow-up showed comparable 
improvements in depression- and disease-related variables in both study arms. The findings 
suggest that monitoring patients’ well-being within diabetes check-ups, and following those 
with mild to moderate depressive symptoms could be sufficient at these early stages of 
depression development.        
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